Merck & Co. Statistics
Share Statistics
Merck & Co. has 2.53B shares outstanding. The number of shares has increased by 0.03% in one year.
| Shares Outstanding | 2.53B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.53B |
| Failed to Deliver (FTD) Shares | 2.07K |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 26.23M, so 1.04% of the outstanding shares have been sold short.
| Short Interest | 26.23M |
| Short % of Shares Out | 1.04% |
| Short % of Float | 1.04% |
| Short Ratio (days to cover) | 2.75 |
Valuation Ratios
The PE ratio is 778.71 and the forward PE ratio is 10.49. Merck & Co. 's PEG ratio is 0.12.
| PE Ratio | 778.71 |
| Forward PE | 10.49 |
| PS Ratio | 4.73 |
| Forward PS | 3.8 |
| PB Ratio | 7.56 |
| P/FCF Ratio | 31.09 |
| PEG Ratio | 0.12 |
Enterprise Valuation
Merck & Co. Inc. has an Enterprise Value (EV) of 305.94B.
| EV / Earnings | 838.2 |
| EV / Sales | 5.09 |
| EV / EBITDA | 44.29 |
| EV / EBIT | 103.57 |
| EV / FCF | 33.46 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.93.
| Current Ratio | 1.25 |
| Quick Ratio | 1 |
| Debt / Equity | 0.93 |
| Total Debt / Capitalization | 48.26 |
| Cash Flow / Debt | 0.37 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is 0.8%.
| Return on Equity (ROE) | 0.01% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 0.8% |
| Revenue Per Employee | 858.79K |
| Profits Per Employee | 5.21K |
| Employee Count | 70.00K |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | 1.51B |
| Effective Tax Rate | 0.8 |
Stock Price Statistics
The stock price has increased by -2.87% in the last 52 weeks. The beta is 0.41, so Merck & Co. 's price volatility has been higher than the market average.
| Beta | 0.41 |
| 52-Week Price Change | -2.87% |
| 50-Day Moving Average | 103.54 |
| 200-Day Moving Average | 118.67 |
| Relative Strength Index (RSI) | 48.09 |
| Average Volume (20 Days) | 11.02M |
Income Statement
In the last 12 months, Merck & Co. had revenue of $60.12B and earned $365.00M in profits. Earnings per share was $0.14.
| Revenue | 60.12B |
| Gross Profit | 43.99B |
| Operating Income | 2.95B |
| Net Income | 365.00M |
| EBITDA | 6.91B |
| EBIT | 2.95B |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has $6.84B in cash and $36.27B in debt, giving a net cash position of -$29.43B.
| Cash & Cash Equivalents | 6.84B |
| Total Debt | 36.27B |
| Net Cash | -29.43B |
| Retained Earnings | 53.90B |
| Total Assets | 117.53B |
| Working Capital | 10.78B |
Cash Flow
In the last 12 months, operating cash flow was $13.01B and capital expenditures -$3.86B, giving a free cash flow of $9.14B.
| Operating Cash Flow | 13.01B |
| Capital Expenditures | -3.86B |
| Free Cash Flow | 9.14B |
| FCF Per Share | 3.51 |
Margins
Gross margin is 73.17%, with operating and profit margins of 4.91% and 0.61%.
| Gross Margin | 73.17% |
| Operating Margin | 4.91% |
| Pretax Margin | 3.14% |
| Profit Margin | 0.61% |
| EBITDA Margin | 11.49% |
| EBIT Margin | 4.91% |
| FCF Margin | 15.21% |
Dividends & Yields
MRK pays an annual dividend of $3.24, which amounts to a dividend yield of 3.2%.
| Dividend Per Share | $3.24 |
| Dividend Yield | 3.2% |
| Dividend Growth (YoY) | 5.19% |
| Payout Ratio | 67.78% |
| Earnings Yield | 0.14% |
| FCF Yield | 3.54% |
Analyst Forecast
The average price target for MRK is $130, which is 27.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $130 |
| Price Target Difference | 27.3% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Jun 3, 2021. It was a forward split with a ratio of 131:125.
| Last Split Date | Jun 3, 2021 |
| Split Type | forward |
| Split Ratio | 131:125 |
Scores
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 7 |